Back to Top Skip to main content Skip to sub-navigation

Janssen COVID-19 vaccine returns to Military Health System

Image of Military personnel wearing a face mask and a face shield administering the COVID-19 vaccine. Navy Hospitalman Jared Houchen, Combined Arms Training Center Camp Fuji Branch Health Annex, Gotenba, Shizuoka, Japan, administers the Janssen COVID-19 vaccine to a Marine at the installation March 16. CATC Camp Fuji, which sees a high number of transient training units, was the first installation in Japan to administer the single-dose vaccine (Photo by: Katie Gray, Marine Corps Installations Pacific).

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Coronavirus | COVID-19 Vaccine Efforts

Doses of the Janssen COVID-19 vaccine are now available to those in the Military Health System eligible and authorized to receive COVID-19 vaccinations, said Air Force Col. Jennifer Garrison, DOD COVID-19 Vaccine Program Operation Team Lead for the Department of Defense.

The Food and Drug Administration and the Centers for Disease Control and Prevention gave the greenlight to resuming use of the Janssen (also called Johnson & Johnson) vaccine April 23.

Aligning to the CDC, the MHS plan was subsequently approved by the White House and the CDC, Garrison said.

Defense Health Agency Director Army Lt. Gen. (Dr.) Ronald Place said: "We have full confidence that the J&J vaccine is safe and effective in preventing COVID-19 and that the data shows the vaccine's known potential benefits outweigh its known and potential risks."

The vaccine received FDA emergency use authorization Feb. 27 and was put on pause by the FDA and the CDC April 13 due to a small instance of those vaccinated with the Janssen product developing a rare, but serious blood clotting disorder that has now been named Thrombosis with Thrombocytopenia Syndrome (TTS).

TTS occurred at a rate of about 7 per 1 million vaccinated women between the ages of 18 and 49. For women 50 and older and men of all ages, this adverse event is even more rare.

FDA has added a warning to the Janssen COVID-19 vaccine emergency use authorization and fact sheets regarding the clotting events, CDC said. As of April 23, TTS had not been linked to the Pfizer-BioNTech or Moderna vaccines.

As of April 21, approximately 7.98 million doses of the Janssen COVID-19 vaccine had been administered in the United States, the CDC said in a report released April 27.

More than 2.62 million doses of the Pfizer-BioNTech, Moderna, and Janssen COVID-19 vaccines have been given to those eligible and authorized within the Military Health System (MHS), and more than 438,000 have been administered to MHS beneficiaries at retail pharmacies and other non-DOD sites, Place explained during a news conference April 21.

The Janssen vaccine makes up less than 3% of the doses provided to the Department of Defense, according to the DOD.

So far, Place said, there have been no cases reported in the military of the blood clotting serious adverse event, but data are being reviewed.

Out of an abundance of caution, CDC said it would review the Janssen data through its Advisory Committee on Immunization Practices (ACIP). The committee met April 14 and decided to keep the pause in vaccinations in place while it further reviewed the data from the Janssen large-scale clinical trials and the adverse events. On April 23, the ACIP recommended the restart of Janssen vaccinations.

A review of all available data shows that the one-shot Janssen COVID-19 vaccine's "known and potential benefits outweigh its known and potential risks for those recommended to receive it," the CDC announced April 25.

However, "women younger than 50 years old should be aware of the rare but increased risk of the TTS adverse event, and that there are other COVID-19 vaccine options available for which this risk has not been seen," CDC said.

People who have received the Janssen vaccine who develop severe headaches, abdominal pain, leg pain, or shortness of breath within three weeks after vaccination should contact their health care provider, the CDC said.

The pause allowed the CDC to re-emphasize with health care providers the importance of reporting severe events in people who have received this vaccine, as well as how to report such events. The pause also gave experts time to carefully review all available data and conduct a risk-benefit analysis of the vaccine.

Military vaccination sites have continued local planning and messaging for reintroduction of the Janssen vaccine. Any products or processes that need to be changed based on the CDC's April 27 "Morbidity and Mortality Weekly Report" and its clinicians' briefing will be finalized April 28, Garrison said. The DHA Director's directive to resume vaccinations with any additional guidance or changes required will be produced and published.

The Janssen vaccine is a replication-deficient adenovirus-vectored vaccine like the AstraZeneca/Oxford vaccine, which has not yet received FDA emergency use authorization.

This means it uses a different virus, such as measles or adenovirus, which is genetically engineered so that it can produce coronavirus proteins in the body and trigger the immune system to make antibodies against those proteins.

The viruses used in viral-vector vaccines are weakened or inactivated, so they cannot cause disease or harm humans. Viral-vector vaccines are also relatively fragile and must be maintained at temperatures that allow them to remain intact to work optimally.

The resource center on the Pfizer, Moderna and Janssen vaccines provides a plethora of information for MHS health care professionals.

 

You also may be interested in...

TRICARE Communications DAP Social Media Post 2021

Infographic
4/2/2021
TRICARE Communications DAP Social Media Post 2021

Post this social media content on your digital platforms and social media channels.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | DHA Appointing Portal

TRICARE Communications DAP Infographic 2021

Infographic
4/2/2021
TRICARE Communications DAP Infographic 2021

Infographic stating how to book a COVID vaccine appointment through DAP. Includes what you will be asked and instructions.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | DHA Appointing Portal

TRICARE Communications DAP Screensaver1 New Tool 2021

Infographic
4/2/2021
TRICARE Communications DAP Screensaver1 New Tool 2021

Screensaver introducing explaining the new DHA Appointing Portal.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | DHA Appointing Portal

TRICARE Communications DAP Screensaver2 How To Book 2021

Infographic
4/2/2021
TRICARE Communications DAP Screensaver2 How To Book 2021

Screensaver stating how to book a COVID vaccine appointment through DAP. Includes what you will be asked and instructions.

Recommended Content:

Coronavirus and the COVID-19 Vaccine | DHA Appointing Portal

Moderna and Pfizer

Infographic
4/2/2021
Moderna and Pfizer

Infographic of the timeline of the Pfizer vaccine and Moderna vaccine

Recommended Content:

Coronavirus and the COVID-19 Vaccine | Coronavirus and the COVID-19 Vaccine | Coronavirus and the COVID-19 Vaccine

Your Time to Get Vaccine Infographic

Infographic
3/16/2021
Your Time to Get Vaccine Infographic

A graphic describing the COVID vaccination tiers. Tier 1a includes medical and healthcare workers; Tier 1b includes essential workers, those 75 and up; Tier 1c includes 65 and up, those at-risk; last is the remaining population. Graphics include groups of people wearing masks.

Recommended Content:

Coronavirus and the COVID-19 Vaccine

Digital 65andOver What To Do

Infographic
3/16/2021
Digital 65andOver What To Do

Image of medical personnel wearing masks on the top right. Text reminds beneficiaries ages 65 and over to contact vaccinated persons to submit vaccination documentation to be added to your health record. Includes TRICARE logo on bottom right.

Recommended Content:

Coronavirus and the COVID-19 Vaccine

Printable Pharmacy Insert

Infographic
3/16/2021
Printable Pharmacy Insert

An insert with links to learn more about vaccination options. Options include MTFs, state health departments, and local retail pharmacy. Graphics include medical personnel wearing masks on the bottom as well as the TRICARE logo.

Recommended Content:

Coronavirus and the COVID-19 Vaccine

Digital Family 75andOver WhatToDo

Infographic
3/16/2021
Digital Family 75andOver WhatToDo

Image of medical personnel wearing masks on the top right. Text reminds beneficiaries to help those over the age of 75 make a vaccine appointment.

Recommended Content:

Coronavirus and the COVID-19 Vaccine

Family 65 and Over What To Do

Infographic
3/16/2021
Family 65 and Over What To Do

Image of medical personnel wearing masks on the top right. Text reminds beneficiaries to help those over the age of 65 make a vaccine appointment.

Recommended Content:

Coronavirus and the COVID-19 Vaccine

Screensaver COVID19 Vaccine Costs

Infographic
3/16/2021
Screensaver COVID19 Vaccine Costs

A screensaver graphic of medical personnel on the upper right corner. Text includes a reminder that TRICARE covers the cost of the vaccine, including at retail pharmacies. Note that civilian providers may charge for office visits. TRICARE logo on the bottom right of graphic.

Recommended Content:

Coronavirus and the COVID-19 Vaccine

Screensaver VaxFax 75 And Older

Infographic
3/16/2021
Screensaver VaxFax 75 And Older

Images of syringes, hand soap and person wearing a mask on the left-hand side and includes the TRICARE logo. States that beneficiaries 75 and up are currently being vaccinated and encourages beneficiaries to learn more at TRICARE.mil/covidvaccine.

Recommended Content:

Coronavirus and the COVID-19 Vaccine

Screensaver: You Are At Increased Risk

Infographic
3/16/2021
Screensaver: You Are At Increased Risk

A screensaver graphic listing conditions that put beneficiaries 16-64 in the “at-risk” category. This includes cancer, smoking, kidney disease, and more. Graphics include a group of people wearing masks and the TRICARE logo.

Recommended Content:

Coronavirus and the COVID-19 Vaccine

Digital You Might be Increased Risk

Infographic
3/16/2021
Digital You Might be Increased Risk

A graphic listing conditions that might put beneficiaries 16-64 in the “at-risk” category. This includes asthma cystic fibrosis, hypertension, and more. Graphics include a group of people wearing masks and the TRICARE logo.

Recommended Content:

Coronavirus and the COVID-19 Vaccine

Digital YouHavePharmacyOptionstoReceivetheVaccine

Infographic
3/16/2021
Digital YouHavePharmacyOptionstoReceivetheVaccine

Images of syringes, hand soap, and facemask are on the left-hand side of the graphic. Text describes the availability to get vaccinated at retail pharmacies, with links provided for more information. The TRICARE logo is placed on the bottom right.

Recommended Content:

Coronavirus and the COVID-19 Vaccine
<< < 1 2 3 4 5  ... > >> 
Showing results 61 - 75 Page 5 of 6
Refine your search
Last Updated: August 11, 2022

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.